Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jun 1;9(6):260-262.
doi: 10.15171/ijhpm.2019.118.

Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"

Michael F Drummond  1
Affiliations
Comment

Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"

Michael F Drummond. Int J Health Policy Manag. .

Abstract

A recent paper by Grutters et al makes the case for early health economic modeling in the development of health technologies. A number of examples of the value of early modeling are given, with analyses being performed at different stages in the development of several non-drug health technologies. This commentary acknowledges the contribution of the paper by Grutters et al and argues for an iterative and integrated approach to early modeling, assessing the cost-effectiveness of the technology, the value of future research and the interaction with the manufacturer's pricing and revenue expectations.

Keywords: Early Assessment; Health Economic Modeling; Health Technology Assessment; Innovation; Innovation Policy.

PubMed Disclaimer

Comment on

References

    1. Grutters JPC, Govers T, Nijboer J, Tummers M, van der Wilt GJ, Rovers MM. Problems and promises of health technologies: the role of early health economic modeling. Int J Health Policy Manag. 2019;8(10):575–582. doi: 10.15171/ijhpm.2019.36. - DOI - PMC - PubMed
    1. Backhouse ME, Wonder M, Hornby E, Kilburg A, Drummond M, Mayer FK. Early dialogue between the developers of new technologies and pricing and reimbursement agencies: a pilot study. Value Health. 2011;14(4):608–615. doi: 10.1016/j.jval.2010.11.011. - DOI - PubMed
    1. Rothery C, Claxton K, Palmer S, Epstein D, Tarricone R, Sculpher M. Characterising uncertainty in the assessment of medical devices and determining future research needs. Health Econ. 2017;26 Suppl 1:109–123. doi: 10.1002/hec.3467. - DOI - PubMed
    1. Sculpher M, Drummond M, Buxton M. The iterative use of economic evaluation as part of the process of health technology assessment. J Health Serv Res Policy. 1997;2(1):26–30. doi: 10.1177/135581969700200107. - DOI - PubMed
    1. Drummond M, Griffin A, Tarricone R. Economic evaluation for devices and drugs--same or different? Value Health. 2009;12(4):402–404. doi: 10.1111/j.1524-4733.2008.00476_1.x. - DOI - PubMed

LinkOut - more resources